[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640544":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":18,"locations":26,"responsibleParty":40,"collaborators":44,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":11,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":11,"enrollmentInfo":57,"targetDuration":11,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Fundación para la Investigación Biosanitaria del Principado de Asturias","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Digital Patient-Reported Assessment Pathway","EXPERIMENTAL",null,[13],"Other: Digital Patient-Reported Assessment Pathway",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":11},"Following activation of the MiAsturSalud\u002FSESPA digital pathway, participants will complete the EORTC QLQ-C30 and FACT-Leu remotely after the baseline visit. The baseline digital assessment will be scheduled within 48-72 hours, with an outcome assessment window extending to 7 days. A second digital assessment will be scheduled at 3-6 months. The platform will record questionnaire completion status and elapsed completion time, and caregiver assistance will be documented. The pathway will not generate automated clinical alerts or mandate changes to treatment.",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":11,"email":23},"Maria Antuna-Casal, PhD","CONTACT","+34 661446805","antunamaria@uniovi.es",{"name":25,"role":21,"phone":11,"phoneExt":11,"email":23},"Maria Antuna",[27],{"facility":28,"status":11,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":11},"Hospital Universitario Central de Asturias (HUCA)","Oviedo","Principality of Asturias","33011","Spain","ES",{"type":35,"coordinates":36},"Point",[37,38],-5.84476,43.36029,{"lat":38,"lon":37},{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Teresa Bernal del Castillo","PhD",[45],{"name":46,"class":47},"Otsuka Pharmaceutical Co., Ltd.","INDUSTRY","100640544","digital-patient-reported-assessment-in-older-adults-with-acute-leukemia-100640544",false,"NCT07597590","Digital Patient-Reported Assessment in Older Adults With Acute Leukemia","Feasibility of a Structured Digital Patient-Reported Assessment Pathway in Older Adults With Acute Leukemia: A Prospective Single-Center Pilot Study","Inclusion Criteria:\n\n* Age 65 years or older.\n* Confirmed diagnosis of acute leukemia of myeloid or lymphoid origin.\n* Active ambulatory follow-up in the Hematology Service at Hospital Universitario Central de Asturias.\n* Ability to understand the questionnaires and provide their own responses, independently or with practical assistance from a caregiver.\n* Access to a compatible internet-enabled digital device, either personally or through a caregiver.\n* Provision of written informed consent.\n\nExclusion Criteria:\n\n* Cognitive impairment that, in the treating hematologist's clinical judgment, prevents the participant from understanding the questionnaires or providing their own responses, despite permitted practical assistance from a caregiver.\n* Clinical condition that, in the treating hematologist's judgment, precludes completion of the study procedures.\n* Persistent inability to access or use the MiAsturSalud\u002FSESPA platform despite reasonable technical support.","ALL","65 Years",{"count":58,"type":59},20,"ESTIMATED","INTERVENTIONAL",[62],"NA","This pilot study will evaluate the feasibility of implementing a structured digital patient-reported assessment pathway in adults aged 65 years or older with acute leukemia. Following activation of the institutional MiAsturSalud\u002FSESPA platform, participants will complete the EORTC QLQ-C30 and FACT-Leu remotely after the baseline visit and will repeat the digital assessment at 3-6 months. The primary outcome will be completion of at least 80% of the baseline digital assessment within 7 days. Secondary outcomes will be caregiver assistance requirement, non-completion of the planned digital follow-up assessment, and elapsed completion time. The study is not designed to establish clinical efficacy.",[65,66],"Leukemia Acute Myeloid","Leukemia Acute Lymphoid Leukemia (ALL)",[68,69,70,71,72],"acute leukemia","older adults","feasibility study","electronic patient-reported outcomes","digital health implementation","NOT_YET_RECRUITING","2026-08-04",{"date":76,"type":77},"2026-08-06","ACTUAL",{"date":79,"type":59},"2026-12",{"date":81,"type":59},"2028-06",{"name":5,"class":6},1]